February 5, 2020
Merck reported quarterly sales at US$11.9 billion in Q4 in its financial results for the fourth quarter of 2019 and...
January 6, 2020
At the dawn of a new year, INN offers a preview of potential developments in the pharmaceutical market throughout 2020.
January 2, 2020
INN offers a closer look at the path ahead for biotech investors in 2020 as new challenges arise for the...
December 23, 2019
INN takes a look at the pharma trends of 2019 that have shaken up the space this year and created...
November 12, 2019
The European Commission has granted a conditional marketing authorization to ERVEBO, an investigational V920 Ebola Zaire vaccine.
October 15, 2019
In this blockchain update, INN highlights the major trends that took place over the third quarter, from hedging to institutionalization.
September 18, 2019
NewLink Genetics (NASDAQ:NLNK) has announced that the US Food and Drug Administration has accepted Merck’s (NYSE:MRK)’s Biologics License Application and...